John L. Harb
Assistant Dean, Scientific Operations
Director, Office of Biotechnologyjohn.email@example.com
John Harb has been at Einstein
for over 30 years in positions of wide ranging and increasing responsibilities.
John joined the Office of Biotechnology’s predecessor office in 1996 and became
director of the Office in 2001. The Office’s track record of innovation and
asset creation led in 2007 to the establishment of the Office of Business Development,
in which John has an active senior role. In addition to his responsibility for
the Office of Biotechnology, John is also the Assistant Dean for Scientific
Operations, a position he has held since 2000. His responsibilities in the
Dean’s Office focus on laboratory space and resource allocation. He also
serves on several leadership committees, including the Dean’s Executive
Committee and the RPM. John received his B.S. in Environmental Health
from East Carolina University and received his M.S.P.H. from the
University of North Carolina at Chapel Hill.
Director, Office of Business Developmentrichard.firstname.lastname@example.org
Prior to joining
the Albert Einstein College of Medicine in 2001 as assistant director in the
office of biotechnology, Richard Kosman, Sc.M.M., worked as a life sciences
industry investment banker/entrepreneur and developed a track record of
building valuable life sciences products and companies from academic
discoveries. In January 2005, Richard
was promoted to associate director of the office of biotechnology at
Einstein. In July 2007, he was further
promoted to founding director of the new office of business development, which
was created to establish additional collaborations with academic and commercial
entities and to further translate the basic research advances made at Einstein
into clinical applications.
his A.B. degree in chemistry summa cum laude and Phi Beta Kappa from Harvard
College and received his Sc.M.M. (Master of Medical Sciences) degree from
Harvard Medical School.
serves on the steering committee of the Harold and Muriel Block Institute for
Clinical & Translational Research at Einstein and Montefiore Medical Center
(Block Institute); on the experimental therapeutics advisory council of the Block
Institute; and on the Pfizer Centers for Therapeutic Innovation — Einstein
joint steering committee. Finally, Richard
serves in the Smart Partners Network and on the Board of Directors of Austral
Incuba, the business incubator of Universidad Austral de Chile (a top-5
university in Chile).
David Silva, Ph.D.
Assistant Director, Office of Business Developmentdavid.email@example.com
David Silva, Ph.D., joined the office of business development in late December 2007 as senior business development analyst and was promoted to assistant director in 2010. He is responsible for research tools initiative and participates in the marketing and out-licensing of Einstein’s technologies. David received his B.S. in microbiology from the University of Massachusetts at Amherst and a Ph.D. in biochemistry from Boston University School of Medicine. He began his postgraduate career as a technology licensing associate at Upstate USA, Inc. (now a part of Millipore Corporation), where he focused on in-licensing technologies from the academic and biopharma communities. Most recently, David worked as a business development manager at Invitrogen Corporation, where he was responsible for out-licensing Invitrogen’s proprietary technologies to diagnostic, therapeutic and research tool companies and for enforcing Invitrogen’s intellectual property rights.
Janis Peck Paradiso, M.B.A.
Assistant Director, Office of Business Developmentjanis.firstname.lastname@example.org
Janis Peck Paradiso, M.B.A., joined the office of business development in late December 2007 as business development analyst and was promoted to assistant director in 2010. In this role, she is responsible for the office's internal marketing and branding initiatives, manages the Technology Transfer Intern Program and participates in the marketing, negotiation and licensing of Einstein’s technologies. Before joining Einstein, Janis worked in the Technology Transfer Office at the Research Foundation of the State University of New York (SUNY) for more than four years. In that position, she managed the Downstate Medical Center’s intellectual property portfolio, as well as other technologies from additional SUNY campuses; led licensing negotiations; and participated in marketing activities. Janis received her B.S. degree in computer engineering from Polytechnic Institute of New York University (formerly Polytechnic University) and her M.B.A. from the University at Albany, SUNY.
Ece Auffarth, Ph.D.
Contract and Licensing Manager, Office of Biotechnologyece.email@example.com
Ece Auffarth, Ph.D., joined the office of biotechnology in
October of 2009 as contract and licensing administrator and was promoted to
contract and licensing manager in 2011. In this role, she is responsible
for negotiating, and overseeing a broad range of agreements between Einstein
and its industrial and academic collaborators (e.g., material transfer
agreements, industry-sponsored research agreements, license agreements,
consulting agreements, confidentiality agreements). In addition, she
manages various innovation program collaborations with large pharmaceutical companies (e.g., Pfizer, GlaxoSmithKline, Eli Lilly, etc.). Ece received her B.S. in biology and Ph.D. in molecular
genetics and microbiology from the State University of New York at Stony Brook.
Upon completing her graduate studies, she worked at Darby & Darby P.C. as
scientific advisor. In that position, she was responsible for prosecuting
patent applications, coordinating U.S. and international patent filings and
maintaining client intellectual property portfolios. Prior to joining Einstein,
Ece worked as scientific project manager at New York University, where she was
responsible for managing the administration of a multi-institutional research
program funded by the Bill and Melinda Gates Foundation. Ece is a registered
patent agent with the United States Patent and Trademark Office.